批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/10/16 |
SUPPL-39(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/04/28 |
SUPPL-32(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2022/09/30 |
SUPPL-37(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/05/19 |
SUPPL-36(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/10/14 |
SUPPL-31(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2021/09/15 |
SUPPL-33(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/11/16 |
SUPPL-30(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2020/11/16 |
SUPPL-27(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2019/06/11 |
SUPPL-26(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/01/09 |
SUPPL-23(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2018/11/11 |
SUPPL-24(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/11/03 |
SUPPL-22(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2017/03/24 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/02/26 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2015/07/09 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/08/29 |
SUPPL-13(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2014/08/29 |
SUPPL-12(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2014/08/12 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/04/11 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/01/17 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/01/16 |
SUPPL-9(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2013/09/25 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/09/25 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/04/17 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/02/08 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/02/05 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/08/10 |
SUPPL-7(补充) |
Approval |
REMS |
N/A
|
|
|
2010/04/20 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:LACOSAMIDE 剂型/给药途径:SOLUTION;ORAL 规格:10MG/ML 治疗等效代码:AA
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022255 |
001 |
NDA |
VIMPAT |
LACOSAMIDE |
SOLUTION;ORAL |
10MG/ML |
Prescription |
Yes |
Yes |
AA |
2010/04/20
|
UCB INC |
214672 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;ORAL |
10MG/ML |
Prescription |
No |
No |
AA |
2022/05/19
|
ALKEM LABS LTD |
209301 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;ORAL |
10MG/ML |
Prescription |
No |
No |
AA |
2022/05/31
|
HETERO LABS LTD III |
216151 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;ORAL |
10MG/ML |
Prescription |
No |
No |
AA |
2022/08/26
|
NOVITIUM PHARMA |
206355 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;ORAL |
10MG/ML |
Prescription |
No |
No |
AA |
2022/09/26
|
APOTEX |
216461 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;ORAL |
10MG/ML |
Prescription |
No |
No |
AA |
2023/02/06
|
MEDLEY PHARMS |
215379 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;ORAL |
10MG/ML |
Prescription |
No |
No |
AA |
2023/12/22
|
MSN |
209224 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;ORAL |
10MG/ML |
Prescription |
No |
No |
AA |
2024/01/24
|
AUROBINDO PHARMA LTD |
204839 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;ORAL |
10MG/ML |
Discontinued |
No |
No |
AA |
2024/03/27
|
AMNEAL PHARMS |
215154 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;ORAL |
10MG/ML |
Prescription |
No |
No |
AA |
2024/05/15
|
CHARTWELL RX |